Estrogen receptor inhibition mediates radiosensitization of ER-positive breast cancer models

Endocrine therapy (ET) is an effective first-line therapy for women with estrogen receptor-positive (ER + ) breast cancers. While both ionizing radiation (RT) and ET are used for the treatment of women with ER+ breast cancer, the most effective sequencing of therapy and the effect of ET on tumor rad...

Descripción completa

Detalles Bibliográficos
Autores principales: Michmerhuizen, Anna R., Lerner, Lynn M., Pesch, Andrea M., Ward, Connor, Schwartz, Rachel, Wilder-Romans, Kari, Liu, Meilan, Nino, Charles, Jungles, Kassidy, Azaria, Ruth, Jelley, Alexa, Zambrana Garcia, Nicole, Harold, Alexis, Zhang, Amanda, Wharram, Bryan, Hayes, Daniel F., Rae, James M., Pierce, Lori J., Speers, Corey W.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8913671/
https://www.ncbi.nlm.nih.gov/pubmed/35273179
http://dx.doi.org/10.1038/s41523-022-00397-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8913671/
https://www.ncbi.nlm.nih.gov/pubmed/35273179
http://dx.doi.org/10.1038/s41523-022-00397-y

Ejemplares similares